Menu ×

Global Veterinary Injectable Devices Market to Grow with a CAGR of 4.69% During 2021-2030; Market to Grow on Account of the Growing Need Amongst Animal Owners to Take Care of their Companion Animals and Pets

  • Text Size:

Research Nester published a report titled Veterinary Injectable Devices Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global veterinary injectable devices market in terms of market segmentation by product, usability, materials, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global veterinary injectable devices market is anticipated to grow with a CAGR of 4.69% over the forecast period, i.e., 2021 – 2030. The market is segmented by materials into glass, metal, plastic, and others, out of which, the plastic segment generated the largest revenue of USD 460.5 Million in the year 2020, and is further expected to hold the largest revenue of USD 714.2 Million by the end of 2030, by growing with a CAGR of 4.54% during the forecast period.

The global veterinary injectable devices market is estimated to garner a revenue of USD 1395.4 Million by the end of 2030, up from a revenue of USD 887.0 Million in the year 2020. Growing adoption of pets worldwide, followed by the rising concern for the different types of animal diseases, and the need for timely vaccinations of these animals are some of the major factors anticipated to drive the growth of the global veterinary injectable devices market in the coming years.

The global veterinary injectable devices market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region, out of which, the market in North America region is expected to generate the largest revenue of USD 475.1 Million by the end of 2030, up from a revenue of USD 306.2 Million in the year 2020. Further, in the Asia Pacific, the market is expected to grow with the highest CAGR of 5.96% during the forecast period.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Concern for Different Types of Animal Diseases

In one of the statistics by the World Organisation for Animal Health (OiE), animal diseases linked production losses was known to be over 20%.

Backed by the rising demand for meat and meat products, diary, and the need for farm animals, livestock, and companion animals among others, individuals worldwide are increasingly focusing on animal husbandry procedures so as to keep their animals healthy. Moreover, growing awareness for timely vaccinations of these animals is also expected to drive the demand for veterinary injectable devices, and in turn, boost the market growth.

However, the adverse reactions at the injection site is expected to operate as key restraint to the growth of global veterinary injectable devices market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global veterinary injectable devices market which includes company profiling of Boehringer Ingelheim International GmbH, Henke-Sass, Wolf GmbH, TeleDart USA, H. Hauptner and Richard Herberholz GmbH & Co. KG, Schippers Export BV, Hamilton Company, Merck & Co., Inc. (Allflex), NEOGEN Corporation, Terumo Medical Corporation, Quick Shot Corporation, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global veterinary injectable devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     


Related Press Releases

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved